Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2025-07-22

Clinical Trial Update: Trametinib Treatment for Complicated Vascular Anomalies [Phase 1, Phase 2]

View source ↗

Summary

A clinical trial update indicates trametinib is being studied for complicated vascular anomalies in Phase 1 and Phase 2. The study is currently active but not r…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Trametinib (trametinib)

Snippet

Sponsor: West China Hospital | Conditions: Vascular Anomalies | Phase 1, Phase 2 | Status: ACTIVE_NOT_RECRUITING